Case Studies

CASE STUDY: AnorMED Inc.

Challenge:
Boston based Genzyme Corporation sent Hoggan’s longtime client, AnorMED Inc. an unsolicited take-over bid. 

Solution:
Hoggan worked with AnorMED’s chairs and directors to develop a comprehensive-yet-agile communications plan that would anticipate various potential strategies and outcomes with media relations and direct communications with shareholders.  It took 82 days of negotiations for AnorMED Inc and Genzyme to reach an agreement, all of which, Hoggan supported AnorMED and acted as consultant and facilitator to the negotiations. 

Results:
Genzyme raised its offer from US $8.55 per share to US $13.50 per share – and AnorMED celebrated a $US 580 million bid, concluding one of the largest biotech takeovers in Canadian history.